Year archive

RACURA ONCOLOGY LTD — 2024 filings

All 120 regulatory filings released by RACURA ONCOLOGY LTD (RAC) in 2024, sourced directly from the official regulator.

120 Filings

2024 Period

2024 filings (120)

Filing	Released	Lang
Race Strengthens Board 2 pages 347.1KB Board/Management Information	2024-12-17	English
Race Receives $5.25m RD Tax Refund for Financial Year 2024 2 pages 252.8KB Capital/Financing Update	2024-12-16	English
Race Submits Human Ethics for RC220 Phase 1 Trial 3 pages 754.1KB Regulatory Filings	2024-12-04	English
Race 2024 Annual General Meeting Video Release 2 pages 300.1KB AGM Information	2024-11-27	English
Notification regarding unquoted securities - RAC 9 pages 23.9KB Capital/Financing Update	2024-11-25	English
Appendix 3Y - Dr Serge Scrofani 2 pages 228.0KB Director's Dealing	2024-11-25	English
Race Oncology 2024 Chairs Address and AGM Presentation 29 pages 3.1MB AGM Information	2024-11-24	English
Results of Annual General Meeting 2 pages 268.6KB Declaration of Voting Results & Voting Rights Announcements	2024-11-24	English
Application for quotation of securities - RAC 9 pages 23.7KB Capital/Financing Update	2024-11-21	English
Race Discovers Multiple Novel FTO Inhibitor Candidates 4 pages 425.0KB Capital/Financing Update	2024-11-20	English
Notification regarding unquoted securities - RAC 8 pages 22.0KB Share Issue/Capital Change	2024-11-06	English
Letter to Shareholders, Notice of AGM & Proxy Form 30 pages 948.7KB Proxy Solicitation & Information Statement	2024-10-22	English
Annual Report to Shareholders 62 pages 4.3MB Annual Report FY 2024	2024-10-22	English
Quarterly Activity Report and Appendix 4C 11 pages 1.1MB Interim / Quarterly Report Q1 2025	2024-10-20	English
Application for quotation of securities - RAC 8 pages 20.7KB Share Issue/Capital Change	2024-10-16	English
Date of AGM & Closing Date for Director Nominations 1 AGM Information	2024-10-06	English
Application for quotation of securities - RAC 8 pages 20.7KB Share Issue/Capital Change	2024-10-02	English
Notification of cessation of securities - RAC 5 pages 16.3KB Regulatory Filings	2024-10-01	English
E&P Conference Presentation 25 pages 2.3MB Investor Presentation	2024-09-25	English
Application for quotation of securities - RAC 8 pages 20.7KB Share Issue/Capital Change	2024-09-25	English
HealthInvest 2024 Investor Presentation 20 pages 1.9MB Investor Presentation	2024-09-17	English
Application for quotation of securities - RAC 8 pages 20.7KB Share Issue/Capital Change	2024-09-12	English
Notification of cessation of securities - RAC 5 pages 16.8KB Regulatory Filings	2024-09-04	English
Application for quotation of securities - RAC 8 pages 20.7KB Share Issue/Capital Change	2024-09-04	English
Race Oncology Board Renewal Update 3 pages 813.5KB Board/Management Information	2024-09-01	English
Appendix 3Z - Mary Harney 2 pages 211.6KB Director's Dealing	2024-09-01	English
Appendix 3Z - Phillip Lynch 2 pages 293.9KB Director's Dealing	2024-09-01	English
Appendix 3X - Dr Daniel Tillett 2 pages 183.3KB Director's Dealing	2024-09-01	English
Appendix 3X - Dr Serge Scrofani 2 pages 167.8KB Director's Dealing	2024-09-01	English
Application for quotation of securities - RAC 8 pages 20.7KB Regulatory Filings	2024-08-28	English
Appendix 4E & Annual Report 64 pages 4.5MB Annual Report FY 2024	2024-08-26	English
Corporate Governance Statement 19 pages 423.1KB Governance Information	2024-08-26	English
Appendix 4G 13 pages 391.2KB Regulatory Filings	2024-08-26	English
Application for quotation of securities - RAC 8 pages 20.7KB Capital/Financing Update	2024-08-21	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-08-14	English
Application for quotation of securities - RAC 8 pages 20.8KB Capital/Financing Update	2024-08-08	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-08-05	English
Application for quotation of securities - RAC 8 pages 20.8KB Capital/Financing Update	2024-07-31	English
Bisantrene Phase 2 AML Trial Successful Concludes 3 pages 774.2KB Regulatory Filings	2024-07-29	English
Race to Present at TechKnow July Conference 2 pages 740.5KB Regulatory Filings	2024-07-24	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-07-24	English
Quarterly Activity Report and Appendix 4C 11 pages 1.0MB Interim / Quarterly Report Q4 2024	2024-07-22	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-07-17	English
Bioshares 18th Biotech Summit Presentation 20 pages 3.3MB Investor Presentation	2024-07-11	English
Application for quotation of securities - RAC 8 pages 20.8KB Capital/Financing Update	2024-07-10	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-07-03	English
Distinguished Oncologist Daniel Von Hoff Joins as Consultant 2 pages 769.0KB Board/Management Information	2024-07-01	English
Race In-person Investor Briefing Invitation Perth 2 pages 284.1KB Investor Presentation	2024-06-30	English
Application for quotation of securities - RAC 8 pages 20.8KB Capital/Financing Update	2024-06-26	English
RC220 GLP Non-clinical Toxicology Program Successful 3 pages 762.7KB Regulatory Filings	2024-06-25	English
Race Appoints George Clinical for Phase 1 Trial of RC220 3 pages 762.7KB Capital/Financing Update	2024-06-19	English
Application for quotation of securities - RAC 8 pages 20.8KB Capital/Financing Update	2024-06-19	English
FDA RPD Designation Granted for RC220 Bisantrene 3 pages 787.3KB Regulatory Filings	2024-06-17	English
Bisantrene Highly Active in a Multiple Myeloma Mouse Model 6 pages 669.7KB Regulatory Filings	2024-06-12	English
Application for quotation of securities - RAC 8 pages 20.8KB Share Issue/Capital Change	2024-06-12	English
Notification of cessation of securities - RAC 5 pages 16.3KB Share Issue/Capital Change	2024-06-10	English
US FDA Orphan Drug Designation Awarded to RC220 Bisantrene 3 pages 369.8KB Regulatory Filings	2024-06-10	English
Bonus Options Offer Results 2 pages 325.8KB Capital/Financing Update	2024-06-05	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-06-05	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-06-05	English
Appendix 3Y-Phillip Lynch 2 pages 232.7KB Director's Dealing	2024-05-29	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-05-29	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-05-29	English
Appendix 3Y-Mary Harney 2 pages 232.1KB Director's Dealing	2024-05-29	English
RAC Bonus Options Offer Closing Reminder 2 pages 330.5KB Capital/Financing Update	2024-05-22	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-05-22	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-05-22	English
Application for quotation of securities - RAC 9 pages 23.7KB Capital/Financing Update	2024-05-15	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-05-15	English
Bisantrene with Decitabine Enhances Cancer Cell Killing 6 pages 1.5MB Capital/Financing Update	2024-05-13	English
RAC Investor Presentation May 2024 35 pages 4.3MB Investor Presentation	2024-05-12	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-05-08	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-05-08	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-05-01	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-05-01	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-04-25	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-04-25	English
Quarterly Activity Report & Appendix 4C 10 pages 590.4KB Interim / Quarterly Report Q3 2024	2024-04-17	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-04-17	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-04-17	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-04-10	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-04-10	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-04-03	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-04-03	English
Application for quotation of securities - RAC 9 pages 23.7KB Share Issue/Capital Change	2024-03-27	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-03-27	English
RC220 cGMP Manufacturing Complete 3 pages 334.8KB Capital/Financing Update	2024-03-25	English
Notification of cessation of securities - RAC 5 pages 16.4KB Regulatory Filings	2024-03-21	English
Application for quotation of securities - RAC 8 pages 20.9KB Share Issue/Capital Change	2024-03-20	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-03-20	English
Race Chief Financial Officer Appointment 2 pages 277.7KB Board/Management Information	2024-03-17	English
Professor Erin Howden Joins Race Oncology SAB 3 pages 335.9KB Board/Management Information	2024-03-13	English
Application for quotation of securities - RAC 8 pages 20.9KB Share Issue/Capital Change	2024-03-13	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-03-13	English
Application for quotation of securities - RAC 8 pages 20.9KB Share Issue/Capital Change	2024-03-06	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-03-06	English
Bisantrene shows potent anticancer activity in AML models 3 pages 859.2KB Investor Presentation	2024-03-05	English
Application for quotation of securities - RAC 8 pages 20.9KB Capital/Financing Update	2024-02-28	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-02-28	English
Appendix 4D & Half-Year Financial Statements 31 pages 4.8MB Interim / Quarterly Report H1 2024	2024-02-27	English
Race Receives $4.0m R&D Tax Refund for Financial Year 2023 2 pages 278.2KB Regulatory Filings	2024-02-26	English
Application for quotation of securities - RAC 8 pages 20.9KB Share Issue/Capital Change	2024-02-21	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-02-21	English
Application for quotation of securities - RAC 8 pages 20.9KB Capital/Financing Update	2024-02-14	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Capital/Financing Update	2024-02-14	English
Application for quotation of securities - RAC 8 pages 20.9KB Capital/Financing Update	2024-02-07	English
Notification regarding unquoted securities - RAC 8 pages 21.0KB Share Issue/Capital Change	2024-02-07	English
Application for quotation of securities - RAC 8 pages 30.4KB Share Issue/Capital Change	2024-01-31	English
Notification regarding unquoted securities - RAC 9 pages 31.7KB Capital/Financing Update	2024-01-31	English
Quarterly Activity Report & Appendix 4C 11 pages 670.5KB Interim / Quarterly Report Q2 2024	2024-01-29	English
Application for quotation of securities - RAC 8 pages 30.4KB Share Issue/Capital Change	2024-01-24	English
Notification regarding unquoted securities - RAC 9 pages 31.7KB Share Issue/Capital Change	2024-01-24	English
Application for quotation of securities - RAC 8 pages 30.4KB Share Issue/Capital Change	2024-01-17	English
Notification regarding unquoted securities - RAC 9 pages 31.7KB Capital/Financing Update	2024-01-17	English
Application for quotation of securities - RAC 8 pages 30.4KB Capital/Financing Update	2024-01-11	English
Cleansing Notice 1 page 75.7KB Share Issue/Capital Change	2024-01-11	English
Application for quotation of securities - RAC 8 pages 30.4KB Share Issue/Capital Change	2024-01-10	English
Notification regarding unquoted securities - RAC 9 pages 31.7KB Capital/Financing Update	2024-01-10	English
Application for quotation of securities - RAC 8 pages 30.4KB Share Issue/Capital Change	2024-01-03	English
Notification regarding unquoted securities - RAC 9 pages 31.7KB Capital/Financing Update	2024-01-03	English

Filings by year

2026 60 filings
2025 94 filings
2024 120 filings
2023 89 filings
2022 100 filings
2021 117 filings
2020 117 filings
2019 74 filings
2018 88 filings
2017 51 filings
2016 44 filings